Prefilled Syringes Market Size To Reach $18.12 Billion By 2033

January 2026 | Report Format: Electronic (PDF)

Prefilled Syringes Market Growth & Trends

The global prefilled syringes market size is anticipated to reach USD 18.12 billion by 2033, expanding at a CAGR of 9.7% from 2026 to 2033, according to a new report by Grand View Research, Inc. Key factors driving the market expansion include technological advancements in auto-injectors and growing usage of prefilled syringes owing to its reduced prices per dose.

The current COVID-19 outbreak is expected to have a substantial impact on the industry. The pandemic has resulted in a significant surge in demand for emergency supplies, medical disposables, medicines, and hospital equipment. According to American Pharmaceutical Review in December 2021, COVID-19 vaccines are being created at an unprecedented rate in response to the worldwide pandemic. COVID-19 vaccination doses totaled 7.3 billion by November 9, 2021, with approximately 30.3 million doses provided daily.

As a result of COVID-19, there has been an increase in the production of COVID-19 vaccines, resulting in increased demand for prefilled syringes. For instance, in March 2022, Schott announced further investments in its pharma sector, including expanding its capacity in Hungary for prefillable glass syringe production. The increased capacity is likely to benefit the global market and provide greater supply security for major pharmaceutical corporations and contract manufacturing firms. As a result, due to the outbreak of coronavirus infection in 2020, sales of prefilled syringes increased globally.

Furthermore, emergency syringes used to treat some of COVID-19's most significant side effects such as heart damage have historically been scarce. Despite the heightened demand during the outbreak, manufacturers provide various programs that identifies high-quality, protected supply bases for medications that are or could be added to the national drug scarcity list. For instance, in October 2019, Premier Inc. teamed up with Amphastar Pharmaceuticals, Inc. to provide phytonadione injection and emergency, pre-filled syringes of sulphate, dextrose, sodium bicarbonate, epinephrine, atropine, calcium chloride, and lidocaine to healthcare practitioners through its ProvideGx programme. These characteristics are projected to generate lucrative market growth prospects.

key Request a free sample copy or view report summary: Prefilled Syringes Market Report

Prefilled Syringes Market Report Highlights

The disposable segment dominated the market in 2025 and accounted for the largest share of 95.6% of the overall revenue. Prefilled disposable syringes are single-use, pre-filled devices containing a specific medication, eliminating the need for healthcare professionals or patients to manually draw the drug from vials or ampoules.
The glass segment accounted for the largest share in 2025. The glass acts as a strong barrier against external elements like moisture, oxygen, and light.
The vaccines and immunizations segment accounted for the largest share in 2025. Numerous vaccines require multiple doses to be administered over a period of time.
The hospitals segment dominated the industry and held the largest revenue share in 2025. Hospitals serve as the primary centers for diagnosis, management, and various types of illness & disorder treatment.
The prefilled syringes market in Europe accounted for the largest revenue share of 37.1% in 2025. Growth in the region can be attributed to the increasing prevalence of chronic diseases, such as diabetes, which require regular medication